from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1740/vapB34

LFCtreatmentdescriptionclass of inhibitor

1.315

Amikacinug/mL Amikacintranslation

1.818

Cap5-10ug/mL Capreomycintranslation

1.819

Rox10-50 ug/mL Roxithromycintranslation

-0.528

SM2-5 ug/mL Streptomycintranslation

1.114

Tet5-10 ug/mL Tetracyclinetranslation

-0.909

Rif0.2-5ug/mL Rifampicintranscription

-0.148

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.936

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.628

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

0.698

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.472

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.830

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.666

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.891

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.596

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.502

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.269

Nigericin50 uM Nigericinrespiration

0.158

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

-0.637

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.461

menadione6-10 ug/mL Menadionerespiration

0.108

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.235

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.041

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.395

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.981

NRP_1Non-replicating persistence stage 1dosRassociated

-0.801

Amp0.2mg/mL AmpicillincellWall

-0.193

Cephalexin20-100 ug/mL CephalexincellWall

-0.514

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.034

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.936

EMB10-20 ug/mL EthambutolcellWall

-0.122

Eta12-40 ug/mL EthionamidecellWall

-0.175

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.363

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.729

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.376

BZA0.12 mg/mL BenzamidearomaticAmides

0.013

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.056

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.201

H2O24 mM hydrogen peroxideDNAdamaging

-0.176

Levo10 ug/mL LevofloxacinDNAdamaging

-0.213

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.057

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.762

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.930

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.181

Antimycin12.5-50 ug/mL Antimycin A?

-1.937

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.285

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.033

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.011

PA8240.2-2 ug/mL PA-824?

0.325

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.036

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.543

Verapamil50 uM Verapamil?

0.883

mercaptoethanol2 mM 2-Mercaptoethanol?

0.834

methoxatin10-20 ug/mL Methoxatin?